To further explore the role of O-GlcNAc-CRT at T346 in CSN5-mediated platinum resistance of ovarian carcinoma, CRT deletion cell lines were generated and confirmed using CRISPR/Cas9 and IB (Figure 7D). This evidence concerns the gene CALR and ovarian carcinoma.